Danske Bank (DANSKE NO) affirms FY26 NII slightly above DKK 38bln
A guidance affirmation ahead of, or alongside, results sits in the category of low-information updates: the read-through depends on whether 'slightly above' represents a raise, a hold, or a quiet trim relative to prior language and consensus positioning.
USTR Greer says US feels that Europe should release some diesel stockpiles; Europe is sitting on a reserve of diesel
USTR Greer says Europe should release some diesel inventories; Europe has to act on the issue of excess capacity
Danske Bank (DANSKE NO) affirms FY26 NII slightly above DKK 38bln
Fed's Kashkari says economy keeps surprising him how resilient it is; Fed will do what it needs to do to get inflation back to target
Iran President Pezeshkian says Tehran will never shy away fro dialogue even as the US targeted Iran several times, reports Tasnim
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
For Nordic banks in this cycle, NII guidance has been the central line, since the tailwind from higher rates on deposit spreads has been fading as policy rates come down and deposit betas normalise, making the floor on NII the key marker of how much margin compression management is absorbing. Affirmations of this kind have historically mattered less for the number itself than for what they imply about the other levers: fee income, costs, and the capital return capacity that underpins the sector's valuation case. The follow-ons are the accompanying detail on deposit volumes and margins, any change to cost or loan-loss guidance, and whether peers' prints point the same direction on Nordic NII trajectory. As guidance rather than a hard print, the signal is confirmation of trend rather than new information.
Related headlines
- Kone (KNEBV FH) reportedly prepares sale of TK Elevator's European business to tackle antitrust concerns 2 hours ago
- Novo’s Wegovy (NOVOB DC) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat 2 hours ago
- Gerresheimer (GXI GY) completes the sale of Centor for EUR 1.5bln5 hours ago
- UniCredit (UCG IM) is considering Deutsche Bank's (DBK GY) Michael Diederich as Commerzbank (CBK GY) CEO and plans an extraordinary meeting to overhaul the supervisory board, Handelsblatt reports5 hours ago
- Zealand Pharma (ZEAL DC) announces positive results from the Phase 3 SYNCHRONIZE-2 trial, with survodutide achieves up to 13.1% weight loss alongside significant improvements in glycemic control in people with obesity and type 2 diabetes 6 hours ago
- EUROPEAN OPEN: MU edges up after results/guidance; IFX GY considers future Thailand wafer fab; SAN FP & REGN expand antibody collaboration; UBSG SW investor urges Swiss exit; PNDORA DC says US demand stabilised; LHA GY and AF FP improve TAP bids6 hours ago
- European Movers: Sanofi (SAN FP) +3.4%, Infineon (IFX GY) +2.4%, ASML (ASML NA) +1.3%, UBS (UBSG SW) -1.2%, Land Securities (LAND LN) -1.9%6 hours ago
- European Equity pre-Market Summary - 1st October 2026: European bourses set for a weaker open; Tech gains, taking lead from positive Micron results7 hours ago
- Newsquawk Daily European Equity Opening News - 1st October 20267 hours ago
- CTS Eventim (EVD GY) CFO has stepped down with immediate effect1 day ago
- Antin (ANTIN FP) to sell Vicinity Energy for an enterprise value of c. USD 2.92bln 1 day ago
- Novo Nordisk (NOVOB DC) says obesity cannot be addressed with only one or two products; Co. plans to segment the patient population and expand its portfolio across injectable and oral therapies1 day ago
- EUROPEAN OPEN: UCG IM faces German conditions over CBK GY control; MT NA considers BRL 5bln Pecem steel mill expansion; LUND DC mulls Xeris Biopharma deal; GRG LN raises profit view; TOM2 NA expands MSFT collab1 day ago
- European Movers: Lundbeck (LUND DC) -0.5%, Roche (ROP SW) +0.5%, Saga (SAGA LN) +7%, Greggs (GRG LN) +7%1 day ago
- Additional European Equity News - 30th September 20261 day ago
- European Equity pre-Market Summary - 30th September 2026: Futures point higher, stock-specifics focussed on M&A, investment and pharmaceutical1 day ago
- Newsquawk Daily European Equity Opening News - 30th September 20261 day ago
- Novo (NOVOB DC) says SELECT SWITCH CV data showed semaglutide reduced MACE risk by 6% vs tirzepatide in patients with type 2 diabetes2 days ago
- EUROPEAN OPEN: AZN LN invests USD 2bln in SMMT; NOVOB DC signs USD 2.6bln licence deal; VOW3 GY & Gotion plan EUR 3.22bln battery investment; AIR FP flags slower September deliveries; HLA GY raises FY26 EBITDA view; LISN SW cuts FY26 sales view2 days ago
- Additional European Equity News - 29th September 2026 2 days ago
The whole workspace, free to try.
Try it free